Spexis
Allschwil
About Spexis
Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs. Polyphor was founded in 1996 and is a clinical stage, privately held Swiss specialty pharma company, based in Allschwil near Basel. It focuses on the development of macrocycle drugs that address antibiotic resistance and severe respiratory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $95.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2023)
- Ticker: six:SPEX
- Website: spexisbio.com
- Phone: 41615671601
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/spexis-113840 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.